Stem cells: An overview with respect to cardiovascular and renal disease

Journal of Natural Science, Biology and Medicine

Volumn 1, Issue 1, 2010, Pages 43-52

  Kumar, Rajnish ^a   Sharma, Anju ^b   Pattnaik, Ashok Kumar ^c   Varadwaj, Pritish Kumar ^b  

^a AMITY UNIVERSITY   (India)

^b INDIAN INSTITUTE OF INFORMATION TECHNOLOGY   (India)

^c BIRLA INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cardiovascular disease; Renal disease; Stem cells

Indexed keywords

EID: 84867384325     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.71674     Document Type: Review

References (68)

1. Becker AJ, McCulloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963;197:452-4.
2. McCulloch EA, Till JE, Siminovitch L. The distribution of colonyforming cells among spleen colonies. J Cell Comp Physiol 1963;62:327-36.
3. Tuch BE. Stem cells: A clinical update. Aust Fam Physician 2006;35:719-21.
4. Igor EK. The Man behind the Unitarian Theory of Hematopoiesis. Perspect Biol Med 2000;43:269-76.
5. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, et al. Precursors for fi broblasts in diff erent populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1973;2:83-92.
6. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-6.
7. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7.
8. Cibelli JB, Lanza RP, West MD, Ezzell C. The fi rst human cloned embryo. Sci Am 2002;286:44-51.
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors. Cell 2006;126:663-76.
10. De-Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-6.
11. Mitalipov SM, Zhou Q, Byrne JA, Ji WZ, Norgren RB, Wolf DP, et al. Reprogramming following somatic cell nuclear transfer in primates is dependent upon nuclear remodeling. Hum Reprod 2007;22: 2232-42.
12. The Nobel prize in physiology or medicine 2007. Available from: http://www.Nobelprize.org [last retrieved on 2007 Oct 8].
13. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fi broblasts by defi ned factors. Cell 2007;131:1-12.
14. Yu J, Vodyanik MA, Smuga-Ott o K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
15. Wong RC, Pera MF, Pebay A. Role of gap junctions in embryonic and somatic stem cells. Stem Cell Rev 2008;4:283-92.
16. Doss MX, Koehler CI, Gissel C, Hescheler J, Sachinidis A. Embryonic stem cells: A possible source for cell replacement therapy. J Cell Mol Med 2007;8:465-73.
17. Menicanin D, Bartold PK, Zannett ino AC, Gronthos S. Genomic profi ling of mesenchymal stem cells. Stem Cell Rev 2009;5:36-50.
18. Xua Y, Zhua X, Hahma HS, Weia W, Haob E, Hayek A, et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A 2010;107:8129-34.
19. Available from: http://www.reference.com/browse/Progenitor-cell, Sept. 2008
20. Gardner RL. Stem cells: Potency, plasticity and public perception. J Anat 2002;200:277-82.
21. Mitalipov S, Wolf D. Totipotency, pluripotency and nuclear reprogramming. Adv Biochem Eng Biotechnol 2009;114:185-99.
22. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9.
23. Hans RS. The potential of stem cells: An inventory. In: Knoepffl er N, Schipanski D, Sorgner SL, editors. Human biotechnology as Social Challenge, England, Ashgate Publishing, Ltd.; 2007. p. 28
24. Adewumi O, Afl atoonian B, Ahrlund-Richter L. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-16.
25. Encinas JM, Enikolopov G. Identifying and quantitating neural stem and progenitor cells in the adult brain. Methods Cell Biol 2008;85: 243-72.
26. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
27. Oh H, Bradfute SB, Gallardo TD, Nakamuraab T, Gaussinf V, Mishinag Y, et al. Cardiac progenitor cells from adult myocardium: Homing, diff erentiation, and fusion aft er infarction. Proc Natl Acad Sci U S A 2003;100:12313-8.
28. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, et al. Persistent expression of the ATP-binding cassett e transporter, Abcg2, identifi es cardiac SP cells in the developing and adult heart. Dev Biol 2004;265:262-75.
29. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: Observations on stem cells and cardiac repair. J Am Coll Cardiol 2006;47:1777-85.
30. Metsuyanim S, Harari-Steinberg O, Buzhor E, Omer D, Pode- Shakked N, Ben-Hur H, et al. Expression of stem cell markers in the human fetal kidney. PLoS One 2009;4:1-15.
31. Noguchi H, Matsumoto S, Ueda M, Hayashi S, Kobayashi N, Jackson A, et al. Method for isolation of mouse pancreatic stem cells. Transplant Proc 2008;40:422-3.
32. Chaudry A. Stem cell bioengineering. Available from: http://www. scq.ubc.ca/stem-cell-bioengineering/ 2004
33. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ett enger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a fi rst cardiac transplant. J Med Sci 1999;341:1725-30.
34. Available from: http://www.cancer.gov/cancertopics/factsheet/ Therapy/bone-marrow transplant/.2008
35. Available from :http://www.abcnews.go.com/Health/ wireStory?id=3307505/. 2007
36. Wu KH, Cui B, Yu CT, Liu YL. Stem cells: New cell source for myocardial constructs tissue engineering. Med Hypotheses 2006;67:1326-9.
37. Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC. Review: Ex vivo engineering of living tissues with adult stem cells. Tissue Eng 2006;12:3007-19.
38. Hakuno D, Fukuda K, Makino S, Konishi F, Tomita Y, Manabe T, et al. Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation 2002;105:380-6.
39. Fukuda K. Application of mesenchymal stem cells for the regeneration of cardiomyocyte and its use for cell transplantation therapy. Hum Cell 2003;16:83-94.
40. Wu DC, Boyd AS, Wood KJ. Embryonic stem cell transplantation: Potential applicability in cell replacement therapy and regenerative medicine. Front Biosci 2007;12:4525-35.
41. Shostak S. Redefi ning stem cells. Bioessays 2006;28:301-8.
42. Baker M. Adult cells reprogrammed to pluripotency, without tumors. Nat Rep Stem Cells 2007.
43. Goldthwaite CA. The promise of induced pluripotent stem cells (iPSCs). Available from: http://www.stemcells.nih.gov/info/ 2006
44. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100:1249-60.
45. Meier KH, Kaplan B. Waiting time on dialysis as the strongest modifi able risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002;74:1377-81.
46. Available from: http://optn.transplant.hrsa.gov/1999
47. Available from: http://learn.genetics.utah.edu/content/tech/stemcells/ scfuture/ 2010
48. Bitt ner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 1999;199:391-6.
49. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, et al. Regression of metastatic renal-cell carcinoma aft er nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000;343:750-8.
50. Asahara T, Murohara T, Sullivan A, Silver M, Zee RV, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
51. Shantsila E, Watson T, Lip GH. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007;49:741-52.
52. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells aft er acute renal ischemia: Modulation by ischemic preconditioning. Am J Physiol Renal Physiol 2006;291:176-85.
53. Abe-Yoshio Y, Abe K, Miyazaki M, Furusu A, Nishino T, Harada T, et al. Involvement of bone marrow-derived endothelial progenitor cells in glomerular capillary repair in habu snake venom-induced glomerulonephritis. Virchows Arch 2008;453:97-106.
54. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al. Identifi cation of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104:2752-60.
55. Hoesli SJ, Mead LE, Prater D, Javed MJ, Ingram DA, Denne SC. Endothelial colony-forming cells and mesenchymal stem cells from ECMO circuits of term infants. J Perinatol 2010 [In Press].
56. Beyer Nardi N, da Silva Meirelles L. Mesenchyma stem cells: Isolation, in-vitro expansion and characterization. Handb Exp Pharmacol 2006;174:249-82.
57. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008;59:311-25.
58. Available from: Hirsch J. An anniversary for cancer chemotherapy. JAMA 2006 296; 12: 1518-1520.
59. Goker H, Haznedaroglu IC, Chao NJ. Acute graft -vs-host disease: Pathobiology and management. Exp Hematol 2001;29:259-77.
60. Menasché P, Hagège AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
61. Smits PC, van Genus RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. J Am Coll Cardiol 2003;42:2063-9.
62. Dib N, McCarthy P, Campbell A, Yeager M, Pagani FD, Wright S, et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant 2005;14: 11-9.
63. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, et al. Autologous skeletal myoblasts transplanted to ischemiadamaged myocardium in humans: Histological analysis of cell survival and diff erentiation. J Am Coll Cardiol 2003;41:879-88.
64. Dow J, Simkhovich BZ, Kedes L, Kloner RA. Washout of transplanted cells from the heart: A potential new hurdle for cell transplantation therapy. Cardiovasc Res 2005;67:301-7.
65. Müller-Ehmsen J, Whitt aker P, Kloner RA, Dow JS, Sakoda T, Long TI, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002;34: 107-16.
66. Goldthwaite CA Jr. Mending a broken heart: Stem cells and cardiac repair. Available from: http://www.stemcells.nih.gov/info/ scireport/ Chapter6.html 2006
67. Thirabanjasak D, Tantiwongseand K, Thorner PS. Angiomyeloproliferative lesions following autologous stem cell therapy. Am Soc Nephrol 2010;21:1218-22.
68. Available from: http://learn.genetics.utah.edu/content/tech/ stemcells/scfuture/ 2010.